MANÜ Telehealth
MANÜ Telehealth offers compounded GLP-1 injections and named wellness injectables. Product routes are clear, but complete clinician identity, pharmacy assignment and purchase terms need confirmation.
Review by Leah Garner, clinical-evidence editor · Updated October 2026
The short version
The distinct treatment pages help identify questions for a consultation. Request the actual prescriber, dispensing pharmacy and full agreement before relying on broad outcome claims or a starting amount.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
MANÜ Telehealth connects patients with independent providers through a platform operated by Ziggy Telehealth. Its current catalog separates ordinary and microdose semaglutide and tirzepatide programs, with compounded injection formats explicitly described. NAD+ and sermorelin also have dedicated injectable treatment pages. Those routes are clearer than a generic peptide menu, but they do not establish every preparation’s formulation, quantity or compounding status. The platform says it does not itself dispense, ship or distribute medicine, making the actual prescribing and pharmacy responsibilities important to confirm.
What MANÜ Telehealth prescribes, by goal
Weight
- SemaglutideFDA-approved
- Injection (compounded)Price not published
- TirzepatideFDA-approved
- Injection (compounded)Price not published
The standard compounded injection pages describe weekly semaglutide and tirzepatide, while microdose programs are separate choices. Their claims about study-related weight-loss percentages should not be taken as a prediction for the exact compounded prescription supplied. The current pages acknowledge that compounded medicines are not FDA-approved. Ask why that preparation is appropriate, whether an approved alternative can meet the need and how the clinician evaluates tolerability and dose changes. A small starting amount is not a clinical reason to prefer one regimen over another.
Longevity
- NAD+Compounding conditions apply
Listed by the seller; no price we hold.
The NAD+ and sermorelin pages identify injectable administration and discuss energy, recovery, sleep or aging goals. The normal role of a molecule or a hormonal mechanism does not establish every advertised clinical benefit. Ask for the actual preparation, evidence relevant to the intended use and monitoring plan. A general statement that prescriptions come from a US 503A pharmacy does not identify the facility or classify every product as compounded.
Recovery
- SermorelinCompounding conditions apply
Listed by the seller; no price we hold.
Sleep
- SermorelinCompounding conditions apply
Listed by the seller; no price we hold.
Who prescribes
A licensed clinician
The service does not name a fully identified treating clinician or separate prescribing medical practice in the reviewed pages. Its team section lists first names and nursing roles, without the fuller details needed to identify the assigned professional independently. Other program copy refers to a board-certified physician, so ask who actually reviews and signs the individual prescription rather than treating those descriptions as interchangeable. The platform’s commercial operator is not itself a licensed medical provider. The patient should receive the clinician’s full name, professional practice and state authorization before clinical care proceeds.
The process begins with an online health assessment followed by a provider’s review and prescription decision. The about page describes regular check-ins and follow-up consultations, with progress tracking and adjustments as needed. Those scheduled features should be explained in the chosen program, including how patients book a live discussion and contact clinical staff between reviews. A round-the-clock support claim does not establish a guaranteed prescriber response at every hour. Confirm the pathway for new symptoms, intolerance or a situation that needs an in-person examination.
Are labs required?
Not mentioned
The reviewed treatment and policy pages do not establish one universal laboratory panel or a complete testing allowance. Ask whether recent results are needed, what additional tests could be ordered and who reviews them. A personalized assessment or general supervision claim does not itself prove a specific test is included. The patient also needs to know how a result requiring care outside the program will be handled, rather than assuming routine progress messaging covers every clinical issue.
Ready to start with MANÜ Telehealth?
Prices and plans are set on the seller's own site.
What it claims, and what it cites
The current pages say prescriptions are filled by a licensed US pharmacy but do not name the dispensing facility. That leaves an important verification step before relying on general quality claims. The marketing also describes study-related outcomes for compounded GLP-1 programs without establishing that the exact preparation has the same evidence as an approved finished product. The treatment decision should address that distinction directly. Terms for a separate nutrition store appear alongside clinical subscription terms, so those rules should not be silently applied to prescription care or interpreted as a complete medicine-return agreement.
How it bills
The ordinary program cards start semaglutide at $199 and tirzepatide at $297, while NAD+ starts at $249 and sermorelin at $279. The public cards do not establish a complete ordinary purchase period or dose allowance for those figures. The terms authorize renewal at the selected subscription frequency and cancellation at the end of the current cycle, generally without partial-period refunds. A separate forty-eight-hour cancellation rule is located within the nutrition-store section, not established as a universal prescription deadline. Obtain the actual first and repeat charge and medication-specific fulfillment cutoff before enrolling.
For and against
- For: Named product pages clearly state injection formats
- For: Regular follow-up and monitoring are described
- For: The platform acknowledges separate prescribing and dispensing roles
- Against: Clinician names and practice identity are incomplete
- Against: The actual pharmacy is not named
- Against: Starting figures do not establish complete purchase periods
- Against: Clinical and nutrition-store policies need careful separation
The evidence behind what it sells
- Semaglutide Side Effects: What the Wegovy Trials and Label Recorded
- NAD Side Effects: What Injection, IV and Oral Precursor Studies Reported
- Sermorelin Side Effects: What the Trials and FDA Record Report
- Tirzepatide Side Effects: What the Zepbound Label and Trials Recorded
- NMN vs NAD: How the Precursor and the Molecule Itself Compare in Human Studies
- Does Sermorelin Work? What the Human Studies Measured
Right for
A patient who can obtain a complete clinical and pharmacy identity and discuss the evidence for the selected preparation before purchase.
Look elsewhere if
Someone treating a starting amount, generic support promise or nutrition-store policy as a complete prescription agreement.
Other sellers for weight
FORM by GBY
Also prescribes Semaglutide, Tirzepatide.
Tuyo Health
Also prescribes Semaglutide, Tirzepatide.
Care Clinics
Also prescribes Semaglutide, Tirzepatide.
MANÜ Telehealth
Frequently asked questions
- Does a first name establish the treating clinician’s credentials?
- No. Ask for the full professional identity, practice and authorization relevant to the actual prescription.
- Do the starting figures identify an ordinary monthly bill?
- The public product cards do not establish that period and complete dose allowance.
- Do nutrition-store cancellation rules automatically apply to prescriptions?
- The terms separate those sections, so obtain the medication-specific agreement rather than assuming identical rules.
Sources
- Care and treatment: Standard semaglutide route and starting amount
- Care and treatment: Tirzepatide and separate microdose offer
- Care and treatment: NAD+ injectable program
- Care and treatment: Sermorelin injectable program
- Care and treatment: Team identity and scheduled follow-up
- Care and treatment: Clinical subscription versus nutrition-store conditions
- Care and treatment: Operator and information-handling policy
See what MANÜ Telehealth prescribes today
MANÜ Telehealth sets its own prices, plans and the states it serves. Check them before you start.